Skip to main content
For U.S. healthcare professionalsRx only

Hydrocortisone Lotion USP, 2%

Itching brings them in. Your assessment guides what comes next.

Hydrocortisone Lotion USP, 2%
Topical lotion, 20 mg/mL. Rx only.

Indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Product overview • 2:15

Captions available

Loading video player

For external use only. Avoid contact with eyes. Contraindicated in patients hypersensitive to any component.

See full Important Safety Information below
Strength
2% (20 mg/mL)
Dosage form
Topical lotion
Status
Rx only

Prescribing and access

Prescribing details

Hydrocortisone Lotion 2% is loaded in most EMRs and can be sent to your local Independent Pharmacy for dispensing.

Dosage and administration. Apply a thin film to the affected area two to four times daily depending on the severity of the condition, per prescribing information.

Available packages and NDCs
PackageNDCAction
1 fl oz (29.6 mL)71297-010-0111-digit format: 71297-0010-01
2 fl oz (59.2 mL)71297-010-0211-digit format: 71297-0010-02

Confirm the product and package selection in your prescribing system. The NDC shown first is the labeled 10-digit format.

Curated product FAQ

Product questions

Answers are drawn from the product labeling. This is not a live chat service.

Important Safety Information

Contraindication

Hydrocortisone Lotion USP, 2% is contraindicated in patients with a history of hypersensitivity to any of the components of the preparation.

For external use only. Avoid contact with eyes.

Systemic effects and absorption

Systemic absorption of topical corticosteroids can cause reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome, hyperglycemia, and glucosuria.

Absorption increases with the use of more potent steroids, application to large surface areas, prolonged use, or the use of occlusive dressings.

Patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression. If suppression is noted, attempt to withdraw the drug, reduce the frequency of application, or substitute a less potent steroid.

Pediatric use

Children may be more susceptible to systemic toxicity from topical corticosteroids. HPA axis suppression, Cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids.

Limit administration to children to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children.

Local reactions, irritation and infection

Local adverse reactions include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.

Discontinue if irritation develops and institute appropriate therapy. In the presence of dermatologic infections, use an appropriate antifungal or antibacterial agent. If a favorable response does not occur promptly, discontinue the corticosteroid until the infection has been adequately controlled.

Pregnancy and nursing

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Do not use extensively, in large amounts, or for prolonged periods in pregnant patients.

Exercise caution when administering to a nursing woman.

Administration guidance for patients

For external use only. Avoid contact with the eyes. Use only as directed by the prescriber. Do not bandage, cover, or wrap the treated skin area unless directed. When treating the diaper area, avoid tight-fitting diapers or plastic pants.

To report SUSPECTED ADVERSE REACTIONS, contact Allegis Holdings, LLC at 1-866-633-9033 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

This is not complete safety information. Please see the full Prescribing Information for additional information.

Resources

Prescribing Information

Full Prescribing Information for Hydrocortisone Lotion USP, 2%, as posted on DailyMed.

Package details

  • 1 fl oz (29.6 mL), NDC 71297-010-01
  • 2 fl oz (59.2 mL), NDC 71297-010-02
View official package label artworkOfficial carton label for Hydrocortisone Lotion USP, 2% as posted on DailyMed

Manufacturer and safety reporting

Visit Allegis Report a side effect

Suspected adverse reactions: Allegis Holdings, LLC at 1-866-633-9033, or FDA at 1-800-FDA-1088.